Neo Ivy Capital Management’s Gilead Sciences GILD Stock Holding History

Neo Ivy Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$802K	Buy	+5,755	New	+$806K	0.21%	164
2025 Q2	–	Sell	-10,948	Closed	-$1.23M	–	405
2025 Q1	$1.23M	Sell	10,948 -25,538	-70%	-$2.64M	0.39%	111
2024 Q4	$3.37M	Buy	+36,486	New	+$3.29M	0.68%	54
2022 Q3	–	Sell	-1,352	Closed	-$83K	–	442
2022 Q2	$83K	Sell	1,352 -2,726	-67%	-$169K	0.22%	167
2022 Q1	$242K	Buy	+4,078	New	+$261K	0.22%	165
2021 Q4	–	Sell	-971	Closed	-$75K	–	503
2021 Q3	$75K	Buy	+971	New	+$68.2K	0.09%	285
2021 Q2	–	Sell	-3,626	Closed	-$234K	–	509
2021 Q1	$234K	Sell	3,626 -5,141	-59%	-$331K	0.26%	143
2020 Q4	$511K	Buy	+8,767	New	+$529K	0.57%	54
2020 Q3	–	Sell	-971	Closed	-$75K	–	517
2020 Q2	$75K	Buy	971 +749	+337%	+$57.4K	0.09%	285
2020 Q1	$17K	Sell	222 -10,601	-98%	-$733K	0.03%	393
2019 Q4	$703K	Buy	10,823 +731	+7%	+$47.6K	0.81%	3
2019 Q3	$641K	Buy	+10,092	New	+$660K	0.42%	103
2019 Q1	–	Sell	-17,984	Closed	-$1.13M	–	324
2018 Q4	$1.13M	Buy	+17,984	New	+$1.26M	0.89%	15

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neo Ivy Capital Management's GILD Position: Q1 2026 in Review

Neo Ivy Capital Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 5,755 shares worth $802K. The stake represents 0.21% of the portfolio and ranks #164 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in GILD as recently as Q1 2025.

Neo Ivy Capital Management first reported a position in GILD in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.37M in Q4 2024. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Neo Ivy Capital Management held 5,755 shares of Gilead Sciences worth $802K as of Q1 2026.
Gilead Sciences was a new Neo Ivy Capital Management position in Q1 2026.
Gilead Sciences made up 0.21% of Neo Ivy Capital Management's portfolio in Q1 2026, its #164 holding.
Neo Ivy Capital Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 13 quarters since.
Neo Ivy Capital Management's Gilead Sciences position peaked at $3.37M in Q4 2024.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.